Adjuvant therapy in premenopausal women with hormone-dependent breast cancer

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer

In recent years, several studies have indicated that aromatase inhibitors (AIS) combined with a gonadotropin-releasing hormone agonist (GnRH agonist) are safe and effective in premenopausal patients with hormone receptor positive (HR+) breast cancer (BCA). The ABCSG-12 trial has shown a comparable D...

Full description

Bibliographic Details
Main Authors: V. F. Semiglazov, V. Yu. Lifanova, V. S. Appolonova
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-11-01
Series:Медицинский совет
Subjects:
breast cancer
aromatase inhibitors
premenopausal women
gnrh agonist
Online Access:https://www.med-sovet.pro/jour/article/view/2750

Similar Items

Similar Items